Publications - Thomas P. Moyer, Ph.D.

Back to research profile

  1. Coats D, Shelton-Dodge K, Ou K, Khun V, Seab S, Sok K, Prou C, Tortorelli S, Moyer TP, Cooper LE, Begley TP, Enders F, Fischer PR, Topazian M. Thiamine deficiency in Cambodian infants with and without beriberi. J Pediatr. 2012 Nov; 161(5):843-7. Epub 2012 Jun 14.
    View PubMed
  2. Schmitt BH, Feder MT, Rokke DL, Moyer TP, Pritt BS. An unusual foreign body in the urinary bladder mimicking a parasitic worm. J Clin Microbiol. 2012 Jul; 50(7):2520-2. Epub 2012 Apr 25
    View PubMed
  3. Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP. Cobalt and Chromium Measurement in Patients with Metal Hip Prostheses. Clinical Chemistry (. 2012; In Press).
  4. Moyer TP, Highsmith WE, Smyrk TC, Gross JB Jr. Hereditary hemochromatosis: laboratory evaluation. Clin Chim Acta. 2011 Aug 17; 412(17-18):1485-92. Epub 2011 Apr 13.
    View PubMed
  5. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16.
    View PubMed
  6. McAlpine DE, Biernacka JM, Mrazek DA, O'Kane DJ, Stevens SR, Langman LJ, Courson VL, Bhagia J, Moyer TP. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine. Ther Drug Monit. 2011 Feb; 33(1):14-20.
    View PubMed
  7. Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR. Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2011 Jan; 64(1):91-6. Epub 2010 Oct 30.
    View PubMed
  8. Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). J Am Coll Cardiol. 2010 Jun 22; 55(25):2804-12. Epub 2010 Apr 08.
    View PubMed
  9. Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, Dupras DM, Chaudhry R, Thapa P, Zinsmeister AR, Heit JA. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc. 2009 Dec; 84(12):1079-94.
    View PubMed
  10. Leung N, Pittelkow MR, Lee CU, Good JA, Hanley MM, Moyer TP. Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis. Nephrology Dialysis Transplantation (NDT Plus) 2009; 2:309-11.
  11. Wilkins BW, Hesse C, Charkoudian N, Nicholson WT, Sviggum HP, Moyer TP, Joyner MJ, Eisenach JH. Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther. 2008 May; 83(5):692-701. Epub 2007 Aug 08.
    View PubMed
  12. Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD. Nicotine percentage replacement among smokeless tobacco users with nicotine patch. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):223-6. Epub 2007 Feb 14.
    View PubMed
  13. Wilkins BW, Hesse C, Sviggum HP, Nicholson WT, Moyer TP, Joyner MJ, Eisenach JH. Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clin Auton Res. 2007 Apr; 17(2):77-84. Epub 2006 Dec 11.
    View PubMed
  14. Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine Tob Res. 2007 Jan; 9(1):43-52.
    View PubMed
  15. Woodworth A, Saunders AN, Koenig JW, Moyer TP, Turk J, Dietzen DJ. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Clin Chem. 2006 Apr; 52(4):743-6. Epub 2006 Feb 02.
    View PubMed
  16. Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, Provost EM. Iqmik: A form of smokeless tobacco used among Alaska Natives. Am J Health Behav. 2005 Nov-Dec; 29(6):588-94.
    View PubMed
  17. Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, Enoch CC, Gill L, Angstman SE, Moyer TP. Iqmik - A form of smokeless tobacco used by pregnant Alaska natives: Nicotine exposure in their neonates. Journal of Maternal-Fetal & Neonatal Medicine. 2005 Apr; 17(4):281-9.
    View PubMed
  18. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005 Jan; 123(1):146-52.
    View PubMed
  19. Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt R. Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav. 2004 Feb; 29(2):349-55.
    View PubMed
  20. Wu AHB, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P. National academy of clinical biochemistry laboratory medicine practice guidelines: Recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003 Mar; 49(3):357-79.
    View PubMed
  21. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem. 2002 Sep; 48(9):1460-71.
    View PubMed
  22. Schroeder DR, Ogburn PL Jr, Hurt RD, Croghan IT, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J Matern Fetal Neonatal Med. 2002 Feb; 11(2):100-7.
    View PubMed
  23. Roberts WL, Annesley TM, De BK, Moulton L, Juenke JM, Moyer TP. Performance characteristics of four free phenytoin immunoassays. Ther Drug Monit. 2001 Apr; 23(2):148-54.
    View PubMed
  24. Ogburn P, Ramin K, Schroeder D, Hurt R, Croghan I, Offord K, Moyer T. Long term nicotine patch use in pregnancy: safety and effectiveness. Am J Obstet Gynecol. 2001; 185(6):S120.
  25. Clouse WD, Yamaguchi H, Phillips MR, Hurt RD, Fitzpatrick LA, Moyer TP, Rowland C, Schaff HV, Miller VM. Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts. J Appl Physiol. 2000 Sep; 89(3):1213-23.
    View PubMed
  26. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 1; 96(1):76-9.
    View PubMed
  27. Hurt RD, Ahlskog JE, Croghan GA, Offord KP, Wolter TD, Croghan IT, Moyer TP. Carbidopa/levodopa for smoking cessation: a pilot study with negative results. Nicotine & Tobacco Research. 2000; 2:71-8.
    View PubMed
  28. Ogburn PL Jr, Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 1999 Sep; 181(3):736-43.
    View PubMed
  29. Moyer TP, Temesgen Z, Enger R, Estes L, Charlson J, Oliver L, Wright A. Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study. Clin Chem. 1999 Sep; 45(9):1465-76.
    View PubMed
  30. Nixon DE, Burritt MF, Moyer TP. The determination of mercury in whole blood and urine by inductively coupled plasma mass spectrometry. Spectrochim Acta B. 1999 Aug 9; 54(8):1141-53.
  31. Nixon DE, Moyer TP, Burritt MF. The determination of selenium in serum and urine by inductively coupled plasma mass spectrometry: comparison with Zeeman graphite furnace atomic absorption spectrometry. Spectrochim Acta B. 1999 Jun 14; 54(6):931-42.
  32. Pettersen MD, Driscoll DJ, Moyer TP, Dearani JA, McGregor CG. Measurement of blood serum cyclosporine levels using capillary "fingerstick" sampling: a validation study. Transpl Int. 1999; 12(6):429-32.
    View PubMed
  33. Hurt RD, Offord KP, Croghan IT, Croghan GA, Gomez-Dahl LC, Wolter TD, Dale LC, Moyer TP. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology (Berl) 1998 Nov; 140(1):98-104.
    View PubMed
  34. Weinzweig J, Schnur PL, McConnell JP, Harris JB, Petty PM, Moyer TP, Nixon D. Silicon analysis of breast and capsular tissue from patients with saline or silicone gel breast implants: II. Correlation with connective-tissue disease. Plastic & Reconstructive Surgery. 1998 Jun; 101(7):1836-41.
    View PubMed
  35. Moyer TP, Oliver LK. Supporting pharmaceutical studies for FDA submissions: diversifying the drug monitoring laboratory. Clin Chem. 1998 Feb; 44(2):433-6.
    View PubMed
  36. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997 Mar; 112(3):882-8.
    View PubMed
  37. McConnell JP, Moyer TP, Nixon DE, Schnur PL, Salomao DR, Crotty TB, Weinzweig J, Harris JB, Petty PM. Determination of silicon in breast and capsular tissue from patients with breast implants performed by inductively coupled plasma emission spectroscopy. Comparison with tissue histology. Am J Clin Pathol. 1997 Feb; 107(2):236-46.
    View PubMed
  38. Schnur PL, Weinzweig J, Harris JB, Moyer TP, Petty PM, Nixon D, McConnell JP. Silicon analysis of breast and periprosthetic capsular tissue from patients with saline or silicone gel breast implants. Plast Reconstr Surg. 1996 Oct; 98(5):798-803.
    View PubMed
  39. Nixon DE, Moyer TP. Routine clinical determination of lead, arsenic, cadmium, and thallium in urine and whole blood by inductively coupled plasma mass spectrometry. Spectrochim Acta B. 1996 Jan 15; 51(1):13-25.
  40. Fleming CR, George L, Stoner GL, Tarrosa VB, Moyer TP. The importance of urinary magnesium values in patients with gut failure. Mayo Clin Proc. 1996 Jan; 71(1):21-4.
    View PubMed
  41. Nixon DE, Mussmann GV, Moyer TP. Inorganic, organic, and total mercury in blood and urine: cold vapor analysis with automated flow injection sample delivery. J Anal Toxicol. 1996 Jan-Feb; 20(1):17-22.
    View PubMed
  42. Ho J, Moyer TP, Phillips SF. Chronic diarrhea: the role of magnesium. Mayo Clin Proc. 1995 Nov; 70(11):1091-2.
    View PubMed
  43. Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Guamanian neurodegenerative disease - investigation of the calcium metabolism heavy metal hypothesis. Neurology. 1995 Jul; 45:1340-4.
    View PubMed
  44. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1995 Apr; 80(4):1376-81.
    View PubMed
  45. Bush VJ, Moyer TP, Batts KP, Parisi JE. Essential and toxic element concentrations in fresh and formalin-fixed autopsy tissues. Clin Chem. 1995 Feb; 41:284-294.
    View PubMed
  46. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol. 1994 Oct; 102(4):443-6.
    View PubMed
  47. Ludwig J, Batts KP, Moyer TP, Poterucha JJ. Advances in liver biopsy diagnosis. Mayo Clin Proc. 1994 Jul; 69(7):677-8.
    View PubMed
  48. Moyer TP. Testing for arsenic. Mayo Clin Proc. 1993 Dec; 68(12):1210-1.
    View PubMed
  49. Morgenstern BZ, Milliner DS, Murphy ME, Simmons PS, Moyer TP, Wilson DM, Smith LH. Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study. J Pediatr. 1993 Aug; 123(2):248-51.
    View PubMed
  50. Lieberman N, Plevak D, Moyer T, Rettke S, Raasch R, Southorn P. Is it important to measure magnesium concentrations during and immediately after liver transplantation? Transplant Proc. 1993 Apr; 25(2):1826-7.
    View PubMed
  51. Ludwig J, Batts KP, Moyer TP, Baldus WP, Fairbanks VF. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin Proc. 1993 Mar; 68(3):263-7.
    View PubMed
  52. Herkes GK, Eadie MJ, Sharbrough FW, Moyer TP. Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Research. 1993; 15:47-52.
    View PubMed
  53. Nixon DE, Moyer TP. Arsenic analysis II: rapid separation and quantification of inorganic arsenic plus metabolites and arsenobetaine from urine. Clin Chem. 1992 Dec; 38(12):2479-83.
    View PubMed
  54. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem. 1991 Sep; 37(9):1575-9.
    View PubMed
  55. Moyer TP, Winkels J, Krom R, Wiesner R. Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood. Clin Chem. 1991 Jun; 37(6):1120-1.
    View PubMed
  56. Hayes SN, Moyer TP, Morley D, Bove AA. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog. Am Heart J. 1991 Jun; 121(6 Pt 1):1639-48.
    View PubMed
  57. McCarthy JT, Hodgson SF, Fairbanks VF, Moyer TP. Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis. 1991 May; 17(5):551-61.
    View PubMed
  58. Moyer TP, Mussmann GV, Nixon DE. Blood-collection device for trace and ultra-trace metal specimens evaluated. Clin Chem. 1991 May; 37(5):709-14.
    View PubMed
  59. Zachariah PK, Moyer TP, Theobald HM, Frantz RP, Kurtz SB, McCarthy JT, Smith RL. The pharmacokinetics of racemic verapamil in patients with impaired renal function. J Clin Pharmacol. 1991 Jan; 31(1):45-53.
    View PubMed
  60. Kachel DL, Moyer TP, Martin WJ 2nd. Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol. Journal of Pharmacology & Experimental Therapeutics. 1990 Sep; 254(3):1107-12.
    View PubMed
  61. Martin RW, Duffy J, Engel AG, Lie JT, Bowles CA, Moyer TP, Gleich GJ. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med. 1990 Jul 15; 113(2):124-34.
    View PubMed
  62. Nelson PE, Moyer TP, Thistle JL. Gallstone dissolution in vitro using methyl tert-butyl ether: radiologic selection criteria. Gastroenterology. 1990 May; 98(5 Pt 1):1280-3.
    View PubMed
  63. Nelson PE, Moyer TP, Thistle JL. Dissolution of calcium bilirubinate and calcium carbonate debris remaining after methyl tert-butyl ether dissolution of cholesterol gallstones. Gastroenterology. 1990 May; 98(5 Pt 1):1345-50.
    View PubMed
  64. Moyer TP, et al. Consensus Document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Transplantation Proceedings. 1990; 22(3):1357-61.
    View PubMed
  65. Nixon DE, Moyer TP, Squillace DP, McCarthy JT. Determination of serum nickel by graphite furnace atomic absorption spectrometry with Zeeman-effect background correction: values in a normal population and a population undergoing dialysis. Analyst. 1989 Dec; 114(12):1671-4.
    View PubMed
  66. McCarthy JT, Johnson WJ, Nixon DE, Jenson BM, Moyer TP. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. J Lab Clin Med. 1989 Aug; 114(2):193-9.
    View PubMed
  67. Welsh PW, O'Connell EJ, Sachs MI, Moyer TP, Wick KA, Harrison LI, McCarville SE, Kvam DC. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals. Ann Allergy. 1989 May; 62(5):396-400.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.